piracetam has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alivanis, P; Grekas, D; Kalekou, H; Karamouzis, M; Papayianni, K; Tourkantonis, A | 1 |
| Levykh, AE; Mamchur, VI; Zhilyuk, VI | 1 |
2 other study(ies) available for piracetam and thromboxane a2
| Article | Year |
|---|---|
Acute cyclosporin A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Dogs; Drug Interactions; Kidney; Kidney Tubular Necrosis, Acute; Nifedipine; Piracetam; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2; Time Factors; Vasoconstriction | 1992 |
A study of the mechanisms for antiaggregant activity of pyrrolidone derivatives in rats with chronic hyperglycemia.
Topics: Animals; Diabetes Mellitus, Experimental; Male; Nitric Oxide Synthase; Piracetam; Platelet Aggregation Inhibitors; Pyrrolidines; Pyrrolidinones; Rats; Rats, Wistar; Thromboxane A2 | 2014 |